E. Tauboll et al., Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats, SEIZURE-E J, 8(8), 1999, pp. 490-493
Long-term valproate treatment is associated with polycystic ovaries and end
ocrine disorders in women with epilepsy. The mechanisms responsible for the
se effects are unknown, but both the epilepsy itself and the drug per se ma
y be of importance. The aim of this study was to investigate possible effec
ts of the dug on gonadal structure and function in animals with no epilepti
c disorders. Three groups, each of 15 female Wistar rats, were fed perorall
y with a valproate mixture (50 mg/kg or 200 mg/kg) or central solution once
daily for 90 days, giving mean valproate concentrations within the normal
human range. A significant, 20% increase in ovary weight was found in both
low- (P = 0.027) and high- (P < 0.001) dose animals together with a signifi
cantly increased number of ovarian follicular cysts. Mean serum testosteron
e concentration was significantly reduced in both low- and high-dose animal
s. There was a non-significant trend towards reduced estrogen levels, while
progesterone levels were unchanged. Even if the hormonal changes are somew
hat different from those in humans, the findings demonstrate that changes i
n gonadal structure and endocrine function also occur in intact animals ind
icating a drug-specific effect. Our findings encourages further studies usi
ng animal models to elucidate possible mechanisms involved in the:endocrine
side-effects of antiepileptic drugs. (C) 1999 BEA Trading Ltd.